[go: up one dir, main page]

IL129726A0 - (4R,5S,6S,7R)-Hexahydro-1-(5,(3-aminoindazole) methyl)-3-butyl-5,6-dihydroxy-4,7-bis (phenylmethyl)-2H-1,3-diazepin-2-one its preparation and its use as HIV protease inhibitor - Google Patents

(4R,5S,6S,7R)-Hexahydro-1-(5,(3-aminoindazole) methyl)-3-butyl-5,6-dihydroxy-4,7-bis (phenylmethyl)-2H-1,3-diazepin-2-one its preparation and its use as HIV protease inhibitor

Info

Publication number
IL129726A0
IL129726A0 IL12972697A IL12972697A IL129726A0 IL 129726 A0 IL129726 A0 IL 129726A0 IL 12972697 A IL12972697 A IL 12972697A IL 12972697 A IL12972697 A IL 12972697A IL 129726 A0 IL129726 A0 IL 129726A0
Authority
IL
Israel
Prior art keywords
aminoindazole
diazepin
phenylmethyl
hexahydro
dihydroxy
Prior art date
Application number
IL12972697A
Other languages
English (en)
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of IL129726A0 publication Critical patent/IL129726A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12972697A 1996-11-08 1997-11-04 (4R,5S,6S,7R)-Hexahydro-1-(5,(3-aminoindazole) methyl)-3-butyl-5,6-dihydroxy-4,7-bis (phenylmethyl)-2H-1,3-diazepin-2-one its preparation and its use as HIV protease inhibitor IL129726A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974696P 1996-11-08 1996-11-08
US74710396A 1996-11-08 1996-11-08
PCT/US1997/020036 WO1998020009A1 (en) 1996-11-08 1997-11-04 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor

Publications (1)

Publication Number Publication Date
IL129726A0 true IL129726A0 (en) 2000-02-29

Family

ID=26705295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12972697A IL129726A0 (en) 1996-11-08 1997-11-04 (4R,5S,6S,7R)-Hexahydro-1-(5,(3-aminoindazole) methyl)-3-butyl-5,6-dihydroxy-4,7-bis (phenylmethyl)-2H-1,3-diazepin-2-one its preparation and its use as HIV protease inhibitor

Country Status (19)

Country Link
EP (1) EP0937066A1 (no)
JP (1) JP2001503429A (no)
KR (1) KR20000053123A (no)
CN (1) CN1235601A (no)
AU (1) AU722489B2 (no)
BR (1) BR9712755A (no)
CA (1) CA2270963A1 (no)
CZ (1) CZ157499A3 (no)
EA (1) EA001154B1 (no)
EE (1) EE9900187A (no)
HU (1) HUP9904143A3 (no)
IL (1) IL129726A0 (no)
LV (1) LV12374B (no)
NO (1) NO992229L (no)
NZ (1) NZ335919A (no)
PL (1) PL333412A1 (no)
SI (1) SI9720071A (no)
SK (1) SK59599A3 (no)
WO (1) WO1998020009A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518094A (ja) * 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Ｈｉｖプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US6194391B1 (en) * 1998-06-24 2001-02-27 Emory University 3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol
FR2810039B1 (fr) 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
AU2871592A (en) * 1991-10-11 1993-05-03 Du Pont Merck Pharmaceutical Company, The Cyclic ureas and analogues useful as retroviral protease inhibitiors

Also Published As

Publication number Publication date
PL333412A1 (en) 1999-12-06
KR20000053123A (ko) 2000-08-25
EA001154B1 (ru) 2000-10-30
SI9720071A (sl) 1999-12-31
CN1235601A (zh) 1999-11-17
EP0937066A1 (en) 1999-08-25
WO1998020009A1 (en) 1998-05-14
BR9712755A (pt) 1999-10-19
LV12374A (lv) 1999-11-20
CA2270963A1 (en) 1998-05-14
EE9900187A (et) 1999-12-15
JP2001503429A (ja) 2001-03-13
NO992229L (no) 1999-06-07
HUP9904143A2 (hu) 2000-06-28
AU722489B2 (en) 2000-08-03
AU5103398A (en) 1998-05-29
NO992229D0 (no) 1999-05-07
HUP9904143A3 (en) 2002-11-28
NZ335919A (en) 2000-09-29
CZ157499A3 (cs) 1999-11-17
SK59599A3 (en) 1999-12-10
EA199900451A1 (ru) 1999-12-29
LV12374B (en) 2000-04-20

Similar Documents

Publication Publication Date Title
HUP9902827A3 (en) Piperidine and piperazine derivatives as muscarinic antagonists, pharmaceutical compositions containing the same and their use
IL151372A0 (en) Cyclopropyl-fused pyrrolidine derivatives and pharmaceutical compositions containing the same
HUP9901155A3 (en) Quinazoline derivatives as vegf inhibitors
IL148517A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL150077A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL146474A0 (en) Benzothiazinone and benzoxazinone compounds
IL145428A0 (en) Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL149883A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0105003A3 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
EP1329456A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZEN DERIVATIVES AND MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
HK1068895A1 (en) Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
IL150550A0 (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
AU2001280135A1 (en) Fibrinogen lowering agents
AU2002218502A1 (en) Lactam compounds and medicinal use thereof
HUP0202249A3 (en) Neurotrophic pyrrolidines and piperidines, compositions containing them and use of the compounds
PL343728A1 (en) Carbapenem derivatives, utilization thereof and intermediate compounds of the same
AU5858000A (en) Switched capacitors
IL129726A0 (en) (4R,5S,6S,7R)-Hexahydro-1-(5,(3-aminoindazole) methyl)-3-butyl-5,6-dihydroxy-4,7-bis (phenylmethyl)-2H-1,3-diazepin-2-one its preparation and its use as HIV protease inhibitor
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
HUP0104146A3 (en) Pyrano, piperidino, and thiapyrano compounds, pharmaceutical compositions thereof and their intermediates
AU2087800A (en) Sock turning device
IL126868A0 (en) Vial for use as syringe accessory
LT99045A (en) (4r,5s,6s,7r)-hexahydro-1-[5-(3-aminoinazole)methyl]-butyl-5,6-dihydroxy-4,7-bis[phenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor